As an estrogen receptor mixed agonist/antagonist, tamoxifen may also influence cell cycle entry and has been shown to have potent effects on proliferation and/or apoptosis of tumor cells via estrogen receptors ERα and ERβ [19]. Here, ESR1 is linked to neoplasm.